secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rani Therapeutics Holdings, Inc. (RANI)
CIK:        0001856725
Form:       8-K
Filed at:   2024-09-11T23:59:59+00:00
Accession:  0000950170-24-105509
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rani Therapeutics dismisses EY as auditor, appoints Marcum; EY's 2023 report had going concern doubt
--------------------------------------------------------------------------------

- EY dismissed as independent auditor on Sep 10, 2024; Marcum LLP appointed immediately.
- EY's 2023 audit opinion included a going concern explanatory paragraph about substantial doubt.
- No disagreements or reportable events in fiscal 2022, 2023, or subsequent interim period.
- Letter from EY to SEC confirming agreement attached as Exhibit 16.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1856725/000095017024105509/0000950170-24-105509-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1856725/000095017024105509/rani-20240910.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-105509

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer